'We Must Innovate': US Biotechs Chart New Growth Path In China
Transparency, Predictability Still Thorny, BIO Hears
Executive Summary
Facing a increasingly competitive environment and tense bilateral relationship, US biotechs must innovate and differentiate while protecting their innovations in China, say panelists at the BIO annual conference.